The Impact of Viral, Molecular, and Immunological Factors on Hepatocellular Carcinoma Recurrence After Curative Resection
Keywords:
Hepatocellular carcinoma; Curative resection; Hepatitis B virus; Tumor microenvironment; BiomarkersAbstract
Background: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and remains a leading causeof cancer-related mortality worldwide. Curative liver resection offers an effective treatment option for patients withpreserved liver function and resectable tumors; however, postoperative recurrence remains the principal challenge, occurring in up to 70% of patients within five years. Tumor recurrence results from a complex interplay between residualmicroscopic disease, de novo hepatocarcinogenesis,
Downloads
References
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38(2):200-207. doi:10.1016/S0168-8278(02)00360-4
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.


